Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Mar-Apr;67(2):154-61.
doi: 10.5014/ajot.2013.006197.

Recruitment, retention, and blinding in clinical trials

Affiliations
Review

Recruitment, retention, and blinding in clinical trials

Stephen J Page et al. Am J Occup Ther. 2013 Mar-Apr.

Abstract

The recruitment and retention of participants and the blinding of participants, health care providers, and data collectors present challenges for clinical trial investigators. This article reviews challenges and alternative strategies associated with these three important clinical trial activities. Common recruiting pitfalls, including low sample size, unfriendly study designs, suboptimal testing locations, and untimely recruitment are discussed together with strategies for overcoming these barriers. The use of active controls, technology-supported visit reminders, and up-front scheduling is recommended to prevent attrition and maximize retention of participants. Blinding is conceptualized as the process of concealing research design elements from key players in the research process. Strategies for blinding participants, health care providers, and data collectors are suggested.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Continuum of selected passive and active recruiting strategies. *Requires a Health Insurance Portability and Accountability Act waiver or other special permissions.

References

    1. American Occupational Therapy Association. 2007. AOTA’s Centennial Vision and executive summary. American Journal of Occupational Therapy, 61, 613–614. http://dx.doi.org/10.5014/ajot.61.6.613 .
    1. Bedlack R. S., Cudkowicz M. E. Clinical trials in progressive neurological diseases: Recruitment, enrollment, retention and compliance. Frontiers of Neurology and Neuroscience. 2009;25:144–151. http://dx.doi.org/10.1159/000209493 . - PubMed
    1. Britton A., Murray D., Bulstrode C., McPherson K., Denham R. Loss to follow-up: Does it matter. Lancet. 1995;345:1511–1512. http://dx.doi.org/10.1016/S0140-6736(95)91071-9 . - PubMed
    1. Cooley M. E., Sarna L., Brown J. K., Williams R. D., Chernecky C., Padilla G., Danao L. L. Challenges of recruitment and retention in multisite clinical research. Cancer Nursing. 2003;26:376–384. quiz 385–386. http://dx.doi.org/10.1097/00002820-200310000-00006 . - PubMed
    1. Corrigan P. W., Salzer M. S. The conflict between random assignment and treatment preference: Implications for internal validity. Evaluation and Program Planning. 2003;26:109–121. http://dx.doi.org/10.1016/S0149-7189(03)00014-4 . - PubMed